Methyl-CpG-Binding Protein 2
                             
                            
                            
                                
                                    
                                            
	"Methyl-CpG-Binding Protein 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				A DNA-binding protein that interacts with methylated CPG ISLANDS. It plays a role in repressing GENETIC TRANSCRIPTION and is frequently mutated in RETT SYNDROME.
    
			
			
				
				
					
						| Descriptor ID | 
										
							D051783
						 | 			
					
					
						| MeSH Number(s) | 
						
							 D12.776.260.536 D12.776.660.235.550 D12.776.664.235.700 
						 | 
					
					
						| Concept/Terms | 
						
							
						 | 
					
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Methyl-CpG-Binding Protein 2".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Methyl-CpG-Binding Protein 2".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Methyl-CpG-Binding Protein 2" by people in this website by year, and whether "Methyl-CpG-Binding Protein 2" was a major or minor topic of these publications. 
				
					
                    To see the data from this visualization as text, 
click here. 
				 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2008 | 1 | 0 | 1 | 
| 2009 | 1 | 0 | 1 | 
| 2012 | 1 | 0 | 1 | 
| 2013 | 1 | 0 | 1 | 
| 2017 | 1 | 0 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Methyl-CpG-Binding Protein 2" by people in Profiles.
						
					
								- 
								
MeCP2 regulated glycogenes contribute to proliferation and apoptosis of gastric cancer cells. Glycobiology. 2017 04 01; 27(4):306-317.
															
								 
							
								- 
								
Functional characterization of the MECP2/IRAK1 lupus risk haplotype in human T cells and a human MECP2 transgenic mouse. J Autoimmun. 2013 Mar; 41:168-74.
															
								 
							
								- 
								
Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups. Ann Rheum Dis. 2013 Mar; 72(3):437-44.
															
								 
							
								- 
								
Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus. Arthritis Rheum. 2009 Apr; 60(4):1076-84.
															
								 
							
								- 
								
Common variants within MECP2 confer risk of systemic lupus erythematosus. PLoS One. 2008 Mar 05; 3(3):e1727.